248 related articles for article (PubMed ID: 16207833)
1. Protective effect of type 2 diabetes on acetaminophen-induced hepatotoxicity in male Swiss-Webster mice.
Sawant SP; Dnyanmote AV; Mitra MS; Chilakapati J; Warbritton A; Latendresse JR; Mehendale HM
J Pharmacol Exp Ther; 2006 Feb; 316(2):507-19. PubMed ID: 16207833
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetic mice are protected from acetaminophen hepatotoxicity.
Shankar K; Vaidya VS; Apte UM; Manautou JE; Ronis MJ; Bucci TJ; Mehendale HM
Toxicol Sci; 2003 Jun; 73(2):220-34. PubMed ID: 12700423
[TBL] [Abstract][Full Text] [Related]
3. Stimulated hepatic tissue repair underlies heteroprotection by thioacetamide against acetaminophen-induced lethality.
Chanda S; Mangipudy RS; Warbritton A; Bucci TJ; Mehendale HM
Hepatology; 1995 Feb; 21(2):477-86. PubMed ID: 7843722
[TBL] [Abstract][Full Text] [Related]
4. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury.
Shayiq RM; Roberts DW; Rothstein K; Snawder JE; Benson W; Ma X; Black M
Hepatology; 1999 Feb; 29(2):451-63. PubMed ID: 9918922
[TBL] [Abstract][Full Text] [Related]
5. Differences in early acetaminophen hepatotoxicity between obese ob/ob and db/db mice.
Aubert J; Begriche K; Delannoy M; Morel I; Pajaud J; Ribault C; Lepage S; McGill MR; Lucas-Clerc C; Turlin B; Robin MA; Jaeschke H; Fromenty B
J Pharmacol Exp Ther; 2012 Sep; 342(3):676-87. PubMed ID: 22647274
[TBL] [Abstract][Full Text] [Related]
6. Increased hepatotoxicity of acetaminophen in Hsp70i knockout mice.
Tolson JK; Dix DJ; Voellmy RW; Roberts SM
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):157-62. PubMed ID: 16280147
[TBL] [Abstract][Full Text] [Related]
7. Immature mice are more susceptible than adult mice to acetaminophen-induced acute liver injury.
Lu Y; Zhang C; Chen YH; Wang H; Zhang ZH; Chen X; Xu DX
Sci Rep; 2017 Feb; 7():42736. PubMed ID: 28205631
[TBL] [Abstract][Full Text] [Related]
8. Calpastatin overexpression prevents progression of S-1,2-dichlorovinyl-l-cysteine (DCVC)-initiated acute renal injury and renal failure (ARF) in diabetes.
Dnyanmote AV; Sawant SP; Lock EA; Latendresse JR; Warbritton AA; Mehendale HM
Toxicol Appl Pharmacol; 2006 Sep; 215(2):146-57. PubMed ID: 16546232
[TBL] [Abstract][Full Text] [Related]
9. Secretory phospholipase A₂-mediated progression of hepatotoxicity initiated by acetaminophen is exacerbated in the absence of hepatic COX-2.
Bhave VS; Donthamsetty S; Latendresse JR; Cunningham ML; Mehendale HM
Toxicol Appl Pharmacol; 2011 Mar; 251(3):173-80. PubMed ID: 21277885
[TBL] [Abstract][Full Text] [Related]
10. Type 2 diabetic rats are sensitive to thioacetamide hepatotoxicity.
Sawant SP; Dnyanmote AV; Warbritton A; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2006 Mar; 211(3):221-32. PubMed ID: 16153671
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic steatohepatitic (NASH) mice are protected from higher hepatotoxicity of acetaminophen upon induction of PPARalpha with clofibrate.
Donthamsetty S; Bhave VS; Mitra MS; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2008 Aug; 230(3):327-37. PubMed ID: 18501395
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of garlic and related organosulfur compounds on acetaminophen-induced hepatotoxicity in mice.
Wang EJ; Li Y; Lin M; Chen L; Stein AP; Reuhl KR; Yang CS
Toxicol Appl Pharmacol; 1996 Jan; 136(1):146-54. PubMed ID: 8560468
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of diallyl sulfone against acetaminophen-induced hepatotoxicity in mice.
Lin MC; Wang EJ; Patten C; Lee MJ; Xiao F; Reuhl KR; Yang CS
J Biochem Toxicol; 1996; 11(1):11-20. PubMed ID: 8806047
[TBL] [Abstract][Full Text] [Related]
14. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice.
Wolf KK; Wood SG; Allard JL; Hunt JA; Gorman N; Walton-Strong BW; Szakacs JG; Duan SX; Hao Q; Court MH; von Moltke LL; Greenblatt DJ; Kostrubsky V; Jeffery EH; Wrighton SA; Gonzalez FJ; Sinclair PR; Sinclair JF
Drug Metab Dispos; 2007 Jul; 35(7):1223-31. PubMed ID: 17392391
[TBL] [Abstract][Full Text] [Related]
15. Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity.
Kostrubsky VE; Szakacs JG; Jeffery EH; Wood SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
Toxicol Appl Pharmacol; 1997 Apr; 143(2):315-23. PubMed ID: 9144448
[TBL] [Abstract][Full Text] [Related]
16. Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity.
Shankar K; Vaidya VS; Corton JC; Bucci TJ; Liu J; Waalkes MP; Mehendale HM
FASEB J; 2003 Sep; 17(12):1748-50. PubMed ID: 12958197
[TBL] [Abstract][Full Text] [Related]
17. Targeting mitochondria with methylene blue protects mice against acetaminophen-induced liver injury.
Lee KK; Imaizumi N; Chamberland SR; Alder NN; Boelsterli UA
Hepatology; 2015 Jan; 61(1):326-36. PubMed ID: 25142022
[TBL] [Abstract][Full Text] [Related]
18. Hepato-protective effects of six schisandra lignans on acetaminophen-induced liver injury are partially associated with the inhibition of CYP-mediated bioactivation.
Jiang Y; Fan X; Wang Y; Tan H; Chen P; Zeng H; Huang M; Bi H
Chem Biol Interact; 2015 Apr; 231():83-9. PubMed ID: 25753323
[TBL] [Abstract][Full Text] [Related]
19. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice.
Zaher H; Buters JT; Ward JM; Bruno MK; Lucas AM; Stern ST; Cohen SD; Gonzalez FJ
Toxicol Appl Pharmacol; 1998 Sep; 152(1):193-9. PubMed ID: 9772215
[TBL] [Abstract][Full Text] [Related]
20. Comparative metabonomic analysis of hepatotoxicity induced by acetaminophen and its less toxic meta-isomer.
Kyriakides M; Maitre L; Stamper BD; Mohar I; Kavanagh TJ; Foster J; Wilson ID; Holmes E; Nelson SD; Coen M
Arch Toxicol; 2016 Dec; 90(12):3073-3085. PubMed ID: 26746206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
